Radiofrequency probes for tissue treatment and methods of use

• US 6,932,814 B2
• Filed: 06/28/2001
• Issued: 08/23/2005
• Est. Priority Date: 07/10/2000
• Status: Expired due to Fees

• Current Assignee: United States Department Of Health And Human Services
• Original Assignee: United States Department Of Health And Human Services
• Inventors: Wood, Bradford J.
• Primary Examiner(s): ROLLINS, ROSILAND STACIE
• Application Number:
  US10/332,297
• Publication Number:
  US 20030208197A1
• Time in Patent Office: 1,517 Days
• Field of Search: 606/41, 606/42, 606 45- 50, 607/98, 607/99, 607/113, 607/116, 607/101, 607/102, 607/128
• US Class Current: 606/41
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 2018/143 multiple needles
• CPC Class Codes: A61B 2018/1432 curved
• CPC Class Codes: A61B 2018/1475 Electrodes retractable in or deployable from a housing
• CPC Class Codes: A61B 2090/3925 ultrasonic

Abstract

A device and method for radiofrequency treatment of tissue is disclosed. The device includes an introducer, a plurality of RF electrodes positionable in a nondeployed state within the introducer, and an electrode advancement element. In the nondeployed state, the RF electrodes are contained within the introducer, and separated from the subject'"'"'s tissue by a plug which substantially occludes the distal end of the introducer. In the method for RF tissue treatment, the introducer is introduced into the tissue of a subject. The RF electrodes are then positioned in the deployed state when the electrode advancement element advances the RF electrodes through the distal end of the introducer, thereby displacing the plug. The electrode advancement element may be a spring-loaded element, and may be actuated by a triggering device on the introducer. The introducer and the RF electrodes may be scored to enhance their visibility in medical imaging studies such as ultrasound, thereby helping to ensure optimal placement of the introducer and the RF electrodes.

Claims

1. A tissue ablation device, comprising:

an introducer having a proximal portion and a distal portion;

one or more RF electrodes movable between a nondeployed state within the introducer, and a deployed state in which the electrodes extend from the distal portion of the introducer;

an electrode advancement element coupled to the RF electrodes and capable of moving the RF electrodes between the nondeployed state and the deployed state; and

an occluder that occludes the distal portion of the introducer when the electrode device is in the nondeployed state, wherein the occluder comprises a plug of biocompatible material mounted for ejection from the distal portion of the introducer when the electrodes are moved to the deployed state.

2. The tissue ablation device of claim 1, further comprising surface irregularities on the introducer.

3. The tissue ablation device of claim 1, further comprising surface irregularities on one or more RF electrodes.

4. The tissue ablation device of claim 1, wherein the electrode advancement element comprises a spring-loaded element that advances the electrode device from the nondeployed state to the deployed state.

5. The tissue ablation device of claim 4 wherein the spring-loaded element is capable of being actuated by a triggering device on the introducer.

6. The tissue ablation device of claim 1, further comprising a housing configured to enclose a proximal end of the introducer and at least a portion of the electrode advancement element.

7. The tissue ablation device of claim 6, wherein the housing and the electrode advancement element are configured to be operable using a single hand.

8. The tissue ablation device of claim 6, wherein the electrode advancement element comprises a spring-loaded element configured to deploy the electrodes through a distal end of the introducer upon actuation of a firing button, the firing button being positioned on an exterior of the housing.

9. The tissue ablation device of claim 8, further comprising a slide switch coupled to the electrode advancement element and operable to move the RF electrodes to a nondeployed state, thereby compressing the spring-loaded element.

10. The tissue ablation device of claim 1, wherein the occluder is positioned at a distal end of the introducer.

11. The tissue ablation device of claim 10, wherein the occluder and the distal end of the introducer are beveled.

12. The tissue ablation device of claim 1, wherein the occluder comprises a material that melts from heat generated during operation of the tissue ablation device.

13. A tissue ablation device, comprising:

an introducer having a proximal portion and a distal portion;

one or more RF electrodes movable between a nondeployed state within the introducer, and a deployed state in which the electrodes extend from the distal portion of the introducer;

an electrode advancement element coupled to the RF electrodes and capable of moving the RF electrodes between the nondeployed state and the deployed state; and

an occluder that occludes the distal portion of the introducer when the electrode device is in the nondeployed state, the occluder comprising a plug of biocompatible material, wherein the biocompatible material is selected from the group consisting of;

collagen, gelatin, pectin, agar, arabic gum, xanthum gum, tragacanth gum, karaya alginic acid, karaya alginate salts, carrageenan, dextrin, starches, celluloses, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, and mannans.

14. A method of ablating tissue in a subject, comprising:

inserting an introducer into the subject;

deploying a plurality of RF electrodes from the introducer into the subject'"'"'s tissue; and

applying RF energy to the RF electrodes;

wherein prior to deployment of the RF electrodes, the introducer'"'"'s distal end is occluded by an occluder, and the occluder comprises a plug of biocompatible material mounted for ejection from the distal end of the introducer when the electrodes are deployed.

15. The method of claim 14, wherein the introducer has surface irregularities.

16. The method of claim 14, wherein one or more of the RF electrodes has surface irregularities.

17. The method of claim 14, wherein the RF electrodes are deployed by a spring-loaded element.

18. The method of claim 17, wherein the spring-loaded element is capable of being actuated by a triggering device.

19. The method of claim 14, wherein the position of the introducer is confirmed by one or more medical imaging methods.

20. The method of claim 14, wherein the position of one or more RF electrodes is confirmed by one or more medical imaging methods.

21. The method of claim 19 or claim 20, wherein the medical imaging method is selected from the group consisting of ultrasound, fluoroscopy, computerized tomography, endoscopy and magnetic resonance imaging.

22. The method of claim 14, wherein deploying the plurality of RF electrodes ejects the occluder from the distal end of the introducer and into the subject.

23. The method of claim 22, further comprising melting the occluder ejected from the distal end of the introducer with heat generated from the RF energy applied to the RF electrodes.

24. The method of claim 22, wherein inserting the introducer into the subject and deploying the plurality of RF electrodes is performed using a single hand of an operator.

25. The method of claim 14, further comprising:

moving the plurality of RF electrodes back to a nondeployed state; and

repositioning the introducer in the subject.

26. The method of claim 25, wherein the moving and repositioning are performed using a single hand of an operator.

27. A method of ablating tissue in a subject, comprising:

inserting an introducer into the subject;

deploying a plurality of RF electrodes from the introducer into the subject'"'"'s tissue; and

applying RF energy to the RF electrodes;

wherein prior to deployment of the RF electrodes, the introducer'"'"'s distal end is occluded by an occluder, the occluder comprising a plug of biocompatible material, wherein the biocompatible material is selected from the group consisting of;

collagen, gelatin, pectin, agar, arabic gum, xanthum gum, tragacanth gum, karaya alginic acid, karaya alginate salts, carrageenan, dextrin, starches, celluloses, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, and mannans.

28. The method of claim 27, wherein the position of the introducer, one or more of the RF electrodes, or both the introducer and the one or more of the RF electrodes is confirmed by one or more medical imaging methods.

29. The method of claim 27, wherein deploying the plurality of RF electrodes ejects the occluder from the distal end of the introducer and into the subject.

30. The method of claim 29, further comprising melting the occluder ejected from the distal end of the introducer with heat generated from the RF energy applied to the RF electrodes.

31. The method of claim 27, wherein inserting the introducer into the subject and deploying the plurality of RF electrodes is performed using a single hand of an operator.